Objective: To review available evidence establishing the validity of the preparticipation evaluation (PPE) as a method for screening health risk prior to participation in exercise and sport. Specific emphasis was placed on reviewing original research evaluating methods to screen participants for risk of sudden cardiovascular death. Literature on the current state of the PPE as a screening tool for athletic participation was examined.
lence of athletic sudden cardiac death (SCD) is estimated at between 1:100,000 and 1:300,000 in high school athletes. 2 In attempts to identify advance risk factors for SCD, The American Heart Association (AHA) recommends routine screening procedures for student athletes. 3 Unfortunately, the very low incidence of symptoms in the underlying disorders make screening extremely difficult and not cost-efficient. Ideally, through a thorough history and physical examination with further cardiac work-up as indicated, the PPE can detect cardiac abnormalities that may put the athlete at risk.
In 1996, the AHA produced recommendations for cardiovascular screening in athletes. 3 This was a response to the consensus of a panel (appointed by the AHA) comprised of cardiovascular specialists, sports medicine physicians, and a legal expert. Guidelines prior to that time had focused on population-based screening for schools. In 1998, another statement was issued by the American College of Sports Medicine (ACSM) and the AHA, making recommendations for cardiovascular screening in all persons before enrollment and participation in sports and fitness activities. 2 Theses recommendations were based on a review of the literature, consensus of the writing group, and previous statements from the AHA and ACSM. The recommendations were then peer reviewed by "selected authorities in the field representing the AHA, ACSM, American College of Cardiology, the International Health Racquet and Sports Clubs Association, and the Young Men's Christian Association." 4 Both the 1998 and the AHA 1996 recommendations involved a more individual approach to preparticipation screening. For young athletes, a history and physical examination (performed by a health care worker trained in detecting cardiovascular diseases) focused to elicit suspicious cardiovascular conditions was recommended. The AHA panel also recommended the development of a national standard for the PPE to address the varied requirements of national sport governing bodies. 3 In 1999, the AHA issued an addendum to these guidelines, advocating the standardization of PPEs across the country, suggesting that they be performed by licensed physicians at a standard consistent with the AHA recommendations for cardiovascular screening procedures. 2 Participation decisions were recommended to be made by qualified physicians and based on current medical specialty eligibility and participation health guidelines. 5 Today, a wide variety of testing methods and PPE formats still exists, and evaluations are performed by a variety of health care professionals, including physicians, athletic trainers, physical therapists, nurses, and chiropractors. 6 In 1997, The Physician and Sports Medicine issued a consensus statement that served as a summary of the 1996 AHA recommendations and preparticipation guidelines. This publication, endorsed by 5 medical societies, presents a comprehensive approach to medical history taking, physical examination, diagnostic screening tools, and disqualification from participation for the sports medicine physician. 1 While such documents are useful additions to the literature, they are considered to be type III evidence (collective expert opinion) since they have not used a rigorous epidemiologic approach to consensus such as face and content validity. However, these types of guidelines are typically referred to as industry standards in medical-legal cases. The ideal situation would be to have practice standards based on consensus statements that follow a formal development approach such as that advocated by the Centers for Disease Control. 7 In addition to questions that identify the best ways to screen for injury and disease, identifying the reasons and circumstances in which full participation should be modified or disallowed has received little research attention. Specific conditions carrying the greatest need for detection are cardiovascular abnormalities that may predispose athletes to sudden death and neurologic problems that predispose athletes to catastrophic injury. Despite nationwide requirements for the PPE, no standardized testing protocol exists. School administrators and health care professionals are struggling to find the most appropriate method to evaluate these athletes. We undertook this critical review of the literature in an attempt to make sense of the current literature and determine if any real evidence for all the current guidelines and recommendations exists. We also sought to establish the existing state of the PPE by reviewing any reports detailing current PPE practices and formats.
METHODS
To review the existing evidence for effectiveness of the PPE, an electronic search was performed on the following da Database of Systematic Reviews, and EBM Reviews. A preparticipation keyword search yielded MeSH headings, which were combined and exploded, as listed in Table 1 . The bibliographies of the final articles selected were scanned to assure no articles were excluded. Searches were restricted to human subjects and English language. There were no restrictions on the basis of age groups, sex, or study methodology, and the aim with the search was to be overinclusive. The list of references was downloaded into EndNote reference manager software, including MeSH headings and abstracts and duplicate references were removed. The titles and abstracts of all references were then reviewed, and articles not directly relevant to the athletic PPE (i.e., not age 35 or younger) were excluded. The relevant original research articles and reviews relating specifically to the PPE were retrieved for all remaining references. The search strategy and results are outlined in Table 1 .
The initial search identified 639 articles after duplicates were removed, and 310 of these were relevant to the PPE in young athletes. These were reviewed, and 25 articles were identified as original research directly relating to the PPE. Table 2 summarizes the strength of evidence of the 22 of the 25 studies. Two of the 25 original PPE articles were descriptions of the process used at particular institutions, and 1 was an intricate cost-effective analysis of the PPE in high school athletes. These were not included in Table 2 as they are not type II evidence or population-based clinical trials. The majority of the literature on the PPE consisted of type III evidence: casebased or opinion papers, position papers from respected authors and sport medicine societies, and reports of expert committees. Although we reviewed all of the retrieved literature, only the original research papers relevant are presented here. The majority of these studies examined cardiovascular diseases and screening procedures. No articles regarding validity of musculoskeletal screening as part of the PPE were found. The original articles identified are grouped and discussed as such:
(1) Eight articles on the nature and extent of cardiovascular disorders in the athletic population (2) Twelve articles on the appropriateness of specific techniques to screen for cardiovascular disease (3) Five articles analyzing the effectiveness and methodology behind the PPE Original research on other important subjects such as heat injury, electrolyte disorders, eating disorders, and pulmonary diseases in young athletes is rare in the literature (this electronic database search revealed only 1 relevant article on asthma in high school athletes and 1 on eating disorders, unrelated to the PPE) and is not discussed in this article. Tables 3 and 4 lists the original research articles that report the incidence of life-threatening cardiovascular disorders in athletes, the risk with sport participation, and PPE screening methods. These studies are a mixture of retrospective and prospective observational and cross-sectional studies from the United States, Italy, and Japan. The retrospective studies analyze the causes of SCD in young athletes and involve small sample sizes. [8] [9] [10] [11] Most of these studies attempt to correlate the cause of death, usually recorded by autopsy or coroners' records, with any documented findings from history and/or physical examinations performed while the athletes were alive. Several prospective studies involve larger populations and document the prevalence of rare congenital conditions, such as anomalous origin of the coronary arteries (AOCA) and hypertrophic cardiomyopathy (HCM), in athletes. [8] [9] [10] [11] The strength of evidence in these and other original re- Table 2 .
RESULTS

Screening for Cardiovascular Diseases That Predispose Athletes to Sudden Cardiac Death
Italy has a national screening system in place for its elite athletes, which has demonstrated a lowering of SCD rates from HCM. 12 Corrado et al 12 evaluated 20 years of PPE screening by prospectively studying sudden deaths among athletes and nonathletes less than 35 years of age in the Venetio region in Italy from 1979 to 1996. Pathologic findings in the athletes were compared with their clinical histories and electrocardiogram (ECG) findings. Arrhythmogenic right ventricular cardiomyopathy was the most common cause (22.4%), followed by CAD (18.4%) and AOCA (12.2%). HCM accounted for only 2% (1) of the deaths among athletes but 7.3% (16) of deaths among nonathletes. HCM was detected in 22 athletes (0.07%) at preparticipation screening and accounted for 3.5% of the cardiovascular reasons for disqualification from sports. None of these 22 athletes died in the 8.2 ± 5-year follow-up period. Thus, the authors conclude that HCM is an uncommon, though detectable, cause of death in young athletes, and preparticipation screening in Italy prevented SCD. Interestingly, though, most of the athletic deaths in Italian athletes are traced to anomalies of the coronary arteries. 12 Pelliccia et al 13 evaluated 1273 athletes in Rome by echocardiography to determine the prevalence of AOCA. In 98.7% of the elite athletes, age 13 to 49 years, from 25 different sports, the origin of the coronary arteries was found to be normal. Variation was seen in 28 athletes, but no abnormal findings were recorded. Based on these results, the authors reported the frequency of AOCA in these elite athletes (notably, many of whom had already been through PPE screening in the Italian sports system) to be <0.1%. These data correlates with research by Zeppilli et al, 14 who found the prevalence of AOCA in 3650 asymptomatic Italian elite athletes screened with transthoracic echography to be 0.09%. Thus, the rarity of this condition, its asymptomatic presentation, and the necessity of diagnosis using echocardiography make the detection AOCA on routine PPE very unrealistic. Basso et al 15 investigated the efficacy of ECG, stress test, and 2-dimensional echocardiography in screening for AOCA as a cause of SCD in 27 athletes. They reported that 10 of the 12 (for whom they had access to prerecorded clinical data) experienced cardiac symptoms, but all had a normal ECG, 2-dimensional echocardiography, and stress test. This study shows that ECG testing for AOCA produces false-negatives, and a normal ECG (at rest or exercise) does not rule out the abnormality. The occurrence of cardiac symptoms experienced by the 10 athletes shortly before sudden death emphasizes the importance of history taking in the PPE, especially focusing on symptoms such as exertional syncope or chest pain. That being said, 15 of 27 (55%) athletes who died had no clinical cardiovascular manifestations or testing during life. Thus, in retrospect, the most appropriate screening methods for this rare and difficult-to-diagnose condition remain uncertain, and the standard PPE (which includes ECG and stress tests in Italy) is limited in its ability to detect AOCA. 13 In the United States, Maron et al 9 found only 3 cases of SCD in Minnesota high school athletes grades 10 to 12 from 440 schools (deaths recorded by a mandatory state insurance program) over a 12-year period. All 3 occurred in males during exertion; 2 were cross-country/track athletes, and 1 was a basketball player. None of the 3 had symptoms on history or cardiac findings on physical examination. The causes of death included anomalous left main coronary artery from the right sinus of Valsalva, aortic valvular stenosis, and myocarditis. The calculated risk for SCD in study participants (651,695 athletes) over the 12 years was 1:500,000, or 1:200,000 per academic year (0.46/100,000 annually) and about 1:130,000 male athletes. These findings underline the limitations of PPE screening, given the rare occurrence of SCD in these largely healthy athletes and the low potential for impact on outcome. Table 5 summarizes the available type II original studies that report the sensitivity and specificity of various cardiac screening tests (by comparing them to echocardiography). These studies attempt to evaluate history, physical examination, and/or ECG for detection of cardiovascular disease that may predispose athletes to SCD. [15] [16] [17] [18] [19] Due to a paucity of evidence and conflicting results, drawing conclusions on the sensitivity of the PPE for detecting potentially lethal cardiovascular diseases utilizing ECG is difficult and often confusing. The AHA guidelines do not advocate the use of ECG in mass screening in the United States; however, in Italy, ECG and exercise stress tests have been and integral part of the mandatory screening protocol of elite athletes for years.
Effectiveness of Cardiovascular Screening Tests
2,12-14 These differences in approaches are provocative and indicate that consensus regarding the sensitivity and specificity of various cardiovascular screening tests to detect occult cardiovascular disease has not been achieved.
For example, ECG and/or limited echocardiography have been indicated for use in mass high school and college screening procedures by some authors, 12 23 studied the efficacy of 2-dimensional and M-mode echocardiography in screening 265 Howard University athletes, 99% of whom were of black ethnicity. Of these athletes, 11% exhibited LV thickness >13 mm, considered to be a possible consequence of training but indistinguishable from mild forms of HCM.
One major difficulty in screening athletes for cardiovascular disorders is the physiologic cardiac adaptations that oc-cur in response to high-volume athletic training. This phenomenon, appropriately termed athlete's heart, produces increased cardiac mass and left ventricular wall thickness-findings hardly discernible from the changes seen in pathologic HCM. In HCM, the heart chambers may be dilated in addition to being hypertrophied, yet the question still remains as to whether or not some athletes with these changes may actually have a mild form of HCM. A gray zone exists in defining and differentiating athlete's heart from HCM, which makes screening difficult.
Electrocardiogram and even echocardiography have high false-positive results in this regard, 3, 20, 23, 24 as physiologic hypertrophy of 13 to 15 mm (13 mm is often used as a cutoff for normal left ventricle wall thickness) may be interpreted as a mild form of HCM. Many athletes have been found (on echocardiography) to exceed this cutoff minimally without having other signs of HCM. 17, 23 Athletes who exhibit increased left ventricle wall thickness tend to be black males participating in sports such as football 17 and rowing. 23 It is still unclear as to whether these changes result from a milder expression of hypertrophic cardiomyopathy, and at which cutoff measurement this could be the case.
Devlin and Ostman-Smith 20 addressed this issue in a small study (sample included 32 athletes, 41 patients with HCM, 66 first-degree relatives and 262 controls). The authors reported that long-axis M-mode and cross-sectional echocardiography could detect HCM versus physiologic cardiovascular training adaptations in athletes. They reported that the best screening measure for HCM was diastolic septum to cavity ratio, with a value of 0.26 yielding a 100% detection rate with no false-positives in the general population. In athletes, these measures yielded a 6% false positive rate with a cutoff of >13 mm for left ventricular wall thickness. Physiologic hypertrophy could then be differentiated from HCM by the absence of Standard PPE limited in ability to detect AOCA hypercontractility (normal systolic left ventricular wall to cavity ratio, 0.63; 0% false-positives.) Contributing further to the confusion over appropriate testing methods, various benign abnormalities are commonly found in athletes' ECGs. In a large prospective study, Peliccia et al 17 found variation in normal ECG patterns in 40% of elite Italian athletes, most of which were due to adaptations to athletic training. Larger cardiac dimensions were found to be associated with abnormal ECG patterns such as increased R or S waves, flat or negative T waves, Q waves, left or right axis deviation, left or right atrial enlargement, and sinus bradycardia. ECG changes were more pronounced in endurance sports. They recorded ECG sensitivity at 51% and specificity at 61%, with a positive predictive value of only 7% for true cardiovascular abnormalities. False-positives resulting from athletic adaptations to training were found to limit the usefulness of ECG as a screening tool.
Fuller et al 18 added ECG to the PPE in a station format in screening for common causes of SCD in young athletes. A cardiac technician performed the ECGs on groups of 50 to 300 athletes in PPEs. The results were computer-interpreted and overread by a cardiologist off site. The estimated cost was $10 per ECG. The authors reported a sensitivity of 60% to 70% and a specificity of 97.4% for ECG pick-up of cardiac disease that might predispose to SCD (such as left ventricular hypertrophy associated with HCM, and rhythm abnormalities.) Of the total 660,000 high school athletes screened, ECG detected cardiac disease in 23 of the 33 predicted by history and physical examination. The false-positive rate reported was 2.6%. In largescale screening efforts, this false-positive rate could translate into considerable added costs (2000 high school athletes in this study were referred for further cardiovascular testing).
In contrast, several studies advocate the efficacy of ECG in large-scale preparticipation screening, especially in detecting HCM. Corrado et al 12 also reported that 75% of the new cases of HCM diagnosed in athletes were diagnosed because ECG was part of the original screening protocol, with referral to echocardiography for positive screens.
Nistri et al 21 also found that ECG proved to be an effective screening tool for HCM. The authors analyzed the efficacy of history, physical examination, chest x-ray, and ECG in screening for HCM in a population of 34,910 male military conscripts in Italy from 1992 to 1996. After a positive initial screen, 2766 recruits were referred for diagnostic echocardiograms. HCM (left ventricle >15 mm) was found in 19 (0.7%), yet 17 of 19 were asymptomatic. All were withdrawn from military duty and were alive and well at 6-year follow-up. The authors reported the sensitivity of ECG as 68% and sensitivity as 94% and advocated that screening with the combination of history, physical examination, and ECG (with referral to echocardiography for suspected cardiovascular abnormalities) could identify HCM in a young, healthy population.
Thus, the literature can establish no consensus as to which screening tests are most effective for detecting cardiovascular risk factors in athletes. ECG in particular is favored by some authors but not others, though poor evidence actually exists for its efficacy. Arbitrary criteria for abnormal ECGs, varying definitions of left ventricular wall thickness/HCM as seen on echocardiogram, variations in testing protocols and sample sizes, and lack of true randomized control trials make it difficult to decipher the discrepancies and variations in the results or to determine an ideal protocol for the cardiovascular portion of the PPE.
Current State of the Preparticipation Evaluation in the United States
Four retrospective cross-sectional reports attempt to assess the completeness of the PPE with respect to inclusion of the formal AHA recommendations for cardiovascular screening in athletes. Three of the 4 observed the PPE process in US high schools athletes and 1 in an NCAA university. All were administered through the athletic director or athletic therapists of the involved schools. 25, 26 In 1 such study, Glover and Maron 26 assessed the adequacy of CV screening in PPEs across 50 states (and the District of Columbia) by comparing the screening procedures to the 1996 AHA consensus and panel guidelines. All 50 states formally required examinations for student athletes, although 8 of them did not actually have an official questionnaire to guide examiners. The authors analyzed the cardiovascular portions of the submitted forms from 43 states that had official questionnaires. Anywhere from 0% to 56% of these forms contained questions specifically recommended for cardiovascular screening. For physical examination, only 5% to 37% of the forms included specific maneuvers directed toward identifying cardiac disease. Blood pressure measurements were not included in the examination in 86% of states. This survey also revealed that 5 of 50 states had absolutely no guidelines or restrictions on PPE examiners, and 11 states actually provided for health care workers with limited or no cardiovascular training, such as chiropractors or naturopaths, to perform the PPEs. None of the 50 states offered standards or qualifications of examiners, and 25 sanctioned nonphysician examiners. Overall, the authors discovered that 40% of state high school associations did not offer standardized PPE forms complying with the AHA recommendations, or had no screening requirement at all.
Other studies report similar findings. Gomez et al 25 found that only 17.2% of high schools used PPE forms with all elements of the cardiac history recommended by the consensus panel, and confirmed that the PPE varies from state to state. However, this study had significant selection and reporting bias, as it was conducted as a mail survey. A sample of 500 from the total population of 2500 athletic trainers registered with the national association was asked to complete a mail sur-vey and submit their PPE forms. A total of 254 trainers responded, and 193 PPE forms were submitted. No outright medical history or examination was required in 7 of these forms: a signature alone from a physician was all that was needed to confirm that the athlete was fit to participate. The authors agreed with the findings of previous research showing that the clinical examination performed in the PPE will closely follow the content of the form, and thus, they advocated the standardization of PPE forms. [27] [28] [29] Koester and Amundson, 30 in a mailed survey analysis of Oregon high schools registered with the Oregon Schools Activities Association, found that 53% of the 142 evaluated forms contained fewer than 5 of the AHA recommendations for cardiac screening. They reported that 42 (27%) of schools were implementing the PPE form that was formally recommended, but not required, by the Oregon Schools Activities Association.
Data on the screening of college athletes are scarce. Pfister et al 6 assessed the cardiac screening methods employed in US NCAA universities between 1995 and 1997. These methods were compared with the 12 AHA recommendations in the 1996 consensus panel screening guidelines. The team physicians or athletic trainers were contacted to elicit the details of scope and format of the PPE. Of the 1110 NCAA colleges and universities surveyed, 879 responded: PPE screening is a requirement at 97%, but only 51% require annual screening. (The AHA currently recommends screening athletes with a history annually and a full history and physical examination as part of a biannual PPE.
2 ) Team physicians conducted the screening process in 85% of the on-campus protocols; however, 19% of schools approved screening by nurse practitioners, and 34% had athletic trainers conducting the examinations. Of the 879 schools that responded, 625 reported using a specific PPE form, and only 26% of these contained at least 9 of the 12 AHA screening guidelines. A quarter of the questionnaires contained 4 or fewer of these recommendations. Relevant history questions regarding symptoms of exertional dyspnea, chest pain, and family history of CVD were included in only 40% of the forms. The authors concluded that the cardiovascular screening techniques employed by US colleges were limited in the ability to detect lethal cardiovascular abnormalities that might predispose to SCD in athletes.
These few studies are a start in the analysis of the current state of the PPE, and their results emphasize the lack of standardization of the process, the randomness of the screening methods employed, and the poor adherence to the AHA guidelines for cardiac screening of student athletes. These reports do not begin to answer the question of the most efficacious or appropriate methods of conducting mass PPEs.
A recent trend may be emerging with the use of electronic or Web-based screening questionnaires. Several schools in the United States are moving to online questionnaires for the PPE. Unfortunately, very few have recorded data on the experience.
In 1997 and 1998, Stanford University implemented a Web-based PPE history form, and Peltz et al 31 reported on the development, implementation, and outcome of this process. The questionnaire was programed into the Stanford Web site for athletes to access online and covered medical and musculoskeletal history, eating, menstrual and sleep disorders, stress, and health risk behaviors. The content was validated by 10 sports medicine physicians and 4 epidemiologists and was found to be 97 ± 2% sensitive in detecting positive responses requiring physician attention. The physicians administering the PPE using the questionnaire reported improvement in their ability to provide overall medical care including health issues beyond clearance. The questionnaire allowed a more focused encounter with the physician and decreased the time needed for each examination. Athletes were compliant and found the online history form easy to use. Databases provided by Webbased PPE questionnaires offer opportunities to study trends, risk factors, and results of interventions and improve health maintenance and preventative care for this population of athletes. 31 Brown University has used a Web-based PPE questionnaire since 2001, and Flore 32 describes the experience in an article in NATA.
A pilot project was also conducted with Ohio high school athletes that demonstrated the ability of a Web-based preparticipation questionnaire to measure the prevalence of positive responses across a variety of health and injury areas. 33 Hunt 34 also subjectively described the variety in PPE protocols in US high schools and colleges, emphasizing the range from mass station-based examinations, to Web-based, to detailed screens involving pulmonary function tests and echocardiograms. This article reiterates the vast discrepancies in procedure and content of the PPE across the United States.
CONCLUSION
It is hard to find data to support a specific approach to the PPE or to establish best practices for risk factor identification. More research is needed to answer questions and help guide the standardization of the process. For instance, what is the most efficient process for the PPE? Who should conduct the examinations? Where and how should they take place? Is a move to an electronic questionnaire an answer?
A few recent research studies have attempted to document and analyze the PPE process, but few data exist on the current state of the PPE in the United States. The PPE is required by most schools in America but is not implemented adequately, and no standardized format currently exists.
A paucity of scientific data on the PPE makes it difficult to establish conclusions regarding the specific content of the PPE. Lack of a standardized format also makes interpretation of the existing articles difficult. Methods of evaluating the PPE format consist mostly of an assessment on whether the screens included the current AHA guidelines. Thus, conclusions on the validity of the PPE have been based on the inclusiveness of these recommendations, rather than on the effective pick-up rates of these screening methods for cardiovascular disease and risk of sudden death in athletes. The evidence for and against the use of ECG, echocardiography, or exercise testing in mass screening of athletes is conflicting, though generally, in the United States, history and physical examination is the most common method of identifying the rare athlete at risk for SCD.
Further research is needed to establish appropriate methods and formats for the PPE. Standardization of the process is required to establish efficient means to carrying out the AHA guidelines for cardiac screening of student athletes.
The literature presented here is a starting point in the evaluation of the current state of the PPE. More data need to be collected to monitor the screening process of student athletes. Use of a standardized examination in electronic format holds promise for the collection of population-based data to evaluate sensitivity and specificity. The ultimate goal of standardizing the PPE is a challenging yet important outcome for which to strive.
